Hui Xue

3.7k total citations
101 papers, 2.9k citations indexed

About

Hui Xue is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Hui Xue has authored 101 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 19 papers in Cancer Research and 16 papers in Oncology. Recurrent topics in Hui Xue's work include RNA Interference and Gene Delivery (13 papers), Advanced biosensing and bioanalysis techniques (9 papers) and Cancer-related molecular mechanisms research (9 papers). Hui Xue is often cited by papers focused on RNA Interference and Gene Delivery (13 papers), Advanced biosensing and bioanalysis techniques (9 papers) and Cancer-related molecular mechanisms research (9 papers). Hui Xue collaborates with scholars based in China, United States and Canada. Hui Xue's co-authors include Ho Lun Wong, Xiao Yu Wu, Shimeng Liu, Ruixue Zhang, Pengbo Guo, Reina Bendayan, Andrew M. Rauth, Ho Him Wong, Cheng‐Hao Jin and Wanting Xu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Hui Xue

99 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hui Xue China	27	1.6k	726	570	434	333	101	2.9k
Deepak Chitkara India	29	1.4k 0.9×	755 1.0×	510 0.9×	519 1.2×	309 0.9×	87	2.7k
Mehdi Dadashpour Iran	38	1.3k 0.8×	915 1.3×	693 1.2×	313 0.7×	297 0.9×	77	3.2k
Meenakshi Malhotra United States	32	1.4k 0.9×	665 0.9×	586 1.0×	428 1.0×	320 1.0×	107	3.2k
Sheema Khan United States	28	1.5k 1.0×	632 0.9×	448 0.8×	584 1.3×	593 1.8×	74	3.0k
Shu‐Fen Peng Taiwan	31	1.8k 1.2×	537 0.7×	270 0.5×	307 0.7×	279 0.8×	109	3.4k
Ommoleila Molavi Iran	27	1.3k 0.8×	541 0.7×	373 0.7×	388 0.9×	507 1.5×	73	2.7k
Anupama Mittal India	25	1.1k 0.7×	565 0.8×	434 0.8×	409 0.9×	186 0.6×	85	2.2k
Wenquan Liang China	31	1.4k 0.9×	635 0.9×	346 0.6×	365 0.8×	241 0.7×	124	2.9k
Maryam Hashemi Iran	33	1.4k 0.9×	829 1.1×	679 1.2×	170 0.4×	374 1.1×	132	3.2k

Countries citing papers authored by Hui Xue

Since Specialization

Citations

This map shows the geographic impact of Hui Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Xue more than expected).

Fields of papers citing papers by Hui Xue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Xue. The network helps show where Hui Xue may publish in the future.

Co-authorship network of co-authors of Hui Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Xue. A scholar is included among the top collaborators of Hui Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Xue. Hui Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xue, Hui, Haimeng Li, Yanhua Liu, et al.. (2025). A CMTM6 Nanobody Overcomes EGFR‐TKI Resistance in Non‐Small Cell Lung Cancer. Advanced Science. 12(27). e2410945–e2410945. 1 indexed citations

Xue, Hui, Weifeng Li, & Yumei Long. (2024). A high-performance enzyme-free glucose sensor based on CuS nanoplates with exposed (110) planes. Colloids and Surfaces A Physicochemical and Engineering Aspects. 703. 135287–135287. 3 indexed citations

Sun, Hui‐Chuan, Xiaodong Zhu, Kui Wang, et al.. (2024). Perioperative pembrolizumab and lenvatinib for resectable hepatocellular carcinoma: A single-arm, multi-center, phase II trial (NeoLEAP-HCC).. Journal of Clinical Oncology. 42(16_suppl). 4120–4120. 3 indexed citations

Li, Ping, Yingying Wang, Tian Li, et al.. (2024). Microscopic Defect Detection on Aircraft Engine Blades via Improved YOLOv8. IEEE Access. 13. 4932–4946.

Zong, Chen, Hui Xue, Yao Li, et al.. (2024). YBX1 promotes stemness and cisplatin insensitivity in intrahepatic cholangiocarcinoma via the AKT/β‐catenin axis. The Journal of Gene Medicine. 26(5). e3689–e3689. 4 indexed citations

Yang, Pinghua, Jianwei Liu, Hui Xue, et al.. (2023). Surgical Margin Affects the Long-Term Prognosis of Patients With Hepatocellular Carcinoma Undergoing Radical Hepatectomy Followed by Adjuvant TACE. The Oncologist. 28(8). e633–e644. 6 indexed citations

Sun, Wei, Nai-Dan Zhang, Tong Zhang, et al.. (2023). Cyanidin-3-O-Glucoside Induces the Apoptosis of Human Gastric Cancer MKN-45 Cells through ROS-Mediated Signaling Pathways. Molecules. 28(2). 652–652. 20 indexed citations

Liu, Jianwei, Yong Xia, Xiaorong Pan, et al.. (2022). Simultaneous versus staged major hepatectomy (≥3 liver segments) for outcomes of synchronous colorectal liver metastases: A systematic review and meta‐analysis. Cancer Reports. 5(8). e1617–e1617. 5 indexed citations

Zhou, Tingting, et al.. (2021). The role of IFT140 in early bone healing of tooth extraction sockets. Oral Diseases. 28(4). 1188–1197. 8 indexed citations

10.

Zhao, Yang, Lei Zhang, Jianwei Liu, et al.. (2021). PD-L1 combined with HDAC9 is a useful prognostic predictor in hepatocellular carcinoma. Translational Cancer Research. 10(5). 2305–2317. 9 indexed citations

11.

Sheng, Yanan, Ying‐Hua Luo, Shaobin Liu, et al.. (2020). <p>Zeaxanthin Induces Apoptosis via ROS-Regulated MAPK and AKT Signaling Pathway in Human Gastric Cancer Cells</p>. OncoTargets and Therapy. Volume 13. 10995–11006. 55 indexed citations

12.

Xue, Feng, Lixue Yang, Binghua Dai, et al.. (2020). Bioinformatics profiling identifies seven immune-related risk signatures for hepatocellular carcinoma. PeerJ. 8. e8301–e8301. 13 indexed citations

13.

Yang, Lixue, Hui Xue, Yanfu Sun, et al.. (2020). CircularRNA-9119 protects hepatocellular carcinoma cells from apoptosis by intercepting miR-26a/JAK1/STAT3 signaling. Cell Death and Disease. 11(7). 605–605. 26 indexed citations

14.

Sun, Yao, Mingxiang Cai, Jiayong Zhong, et al.. (2019). The long noncoding RNA lnc-ob1 facilitates bone formation by upregulating Osterix in osteoblasts. Nature Metabolism. 1(4). 485–496. 47 indexed citations

15.

Liu, Fujun, Xuexia Liu, Xin Liu, et al.. (2019). Integrated Analyses of Phenotype and Quantitative Proteome of CMTM4 Deficient Mice Reveal Its Association with Male Fertility. Molecular & Cellular Proteomics. 18(6). 1070–1084. 19 indexed citations

16.

Wang, Jiaru, Guinan Shen, Ying‐Hua Luo, et al.. (2019). 2-(4-methoxyphenylthio)-5,8-dimethoxy-1,4-naphthoquinone induces apoptosis via ROS-mediated MAPK and STAT3 signaling pathway in human gastric cancer cells. Journal of Chemotherapy. 31(4). 214–226. 12 indexed citations

17.

Xue, Hui, Ting Li, Pingzhang Wang, et al.. (2019). CMTM4 inhibits cell proliferation and migration via AKT, ERK1/2, and STAT3 pathway in colorectal cancer. Acta Biochimica et Biophysica Sinica. 51(9). 915–924. 22 indexed citations

18.

Li, Zhi‐Yun, et al.. (2016). Integrating Sugar and Dopamine into One Polymer: Controlled Synthesis and Robust Surface Modification. Macromolecular Rapid Communications. 38(3). 1600548–1600548. 16 indexed citations

19.

Xue, Hui, et al.. (2014). Nanocarrier for Poorly Water-Soluble Anticancer Drugs—Barriers of Translation and Solutions. AAPS PharmSciTech. 15(4). 822–833. 198 indexed citations

20.

Xue, Hui, et al.. (2011). The inhibitory effect of polypeptide cSN50 on alcoholic hepatic injuries through blocking the binding of NF-κB to importin α. Scandinavian Journal of Gastroenterology. 46(7-8). 931–940. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact